Skip to main content
. 2023 Feb 14;209:107155. doi: 10.1016/j.rmed.2023.107155

Table 3.

Plasma levels of cytokines, chemokines and growth factors.

Conc. (pg/ml) BC C BH H P
IL-1β 9.440 ± 7.50 (0.282–27.61) 9.519 ± 6.12 (0.530–20.50) 8.489 ± 5.660 (0.288–16.47) 9.649 ± 7.97 (0.280–27.56) Ns
IL-1RA 5.608 ± 2.725 (2.04–11.30) 5.762 ± 2.884 (2.000–11.94) 5.380 ± 2.504 (2.16–9.85) 5.565 ± 3.31 (1.000–11.93) Ns
IL-6 0.899 ± 0.6469 (0.162–3.079) 0.870 ± 0.5573 (0.077–2.512) 1.102 ± 0.716 (0.200–3.169) 0.918 ± 0.483 (0.200–1.751) Ns
TNFα 16.31 ± 4.55 (10.09–25.63) 17.35 ± 4.14 (11.13–27.18) 17.61 ± 5.98 (8.40–32.95) 17.11 ± 6.95 (9.60–35.67) Ns
IL-12p70 3.33 ± 1.53 (1.00–6.10) 3.60 ± 1.36 (1.30–6.50) 3.19 ± 1.08 (1–305.00) 3.77 ± 1.30 (1.80–5.50) Ns
MIP1α 20.71 ± 10.30 (2.70–38.00) 21.62 ± 9.92 (7.30–39.20) 20.52 ± 8.368 (4.50–36.90) 23.13 ± 10.38 (4.50–34.40) Ns
IP10 290.20 ± 65.49 (156.7–377.7) 305.50 ± 45.15 (160.0–371.1) 284.50 ± 70.99 (130.3–376.0) 298.30 ± 58.23 (190.00–391.30) Ns
IFNα 98.86 ± 34.22 (29.60–153.5) 100.7 ± 36.43 (36.45–184.5) 108.7 ± 37.57 (41.35–184.5) 99.09 ± 35.96 (46.42–158.9) Ns
IFNγ 0.956 ± 0.720 (0.30–2.20) 1.375 ± 1.125 (0.30–3.30) 0.956 ± 0.713 (0.10–2.40) 1.153 ± 0.786 (0.10–2.20) 0.0535 (##)
IL-15 6.681 ± 2.21 (2.50–9.90) 8.194 ± 3.26 (4.50–14.70) 7.55 ± 2.80 (4.00–15.40) 7.47 ± 2.40 (3-60-10.70) 0.034 (##)
IL-2 0.520 ± 0.408 (0.05–1.43) 0.490 ± 0.333 (0.04–1.35) 0.442 ± 0.345 (0.10–1.50) 0.581 ± 0.442 (0.04–1.60) Ns
VEGF 8.143 ± 4.53 (2.600–17.150) 8.895 ± 6.012 (2.000–26.110) 7.910 ± 2.965 (2.600–13.520) 11.96 ± 8.275 (2.313–34.580) Ns

Data are described as: mean ± SD (minimum-maximum). Abbreviations: BC: baseline control group, C: control group at t = 5 days, BH: baseline HBOT group, H: HBOT group at t = 5 days (n = 20–24 per group). P values for each analyte are listed and derive from paired t tests (H vs BH: #; C vs BC: ##). Significant differences are highlighted. Rest of comparisons are ns (# and ##).